A landmark study by Hyderabad’s L V Prasad Eye Institute (LVPEI), published in the British Journal of Ophthalmology, has ...
About OKYO OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain and dry eye disease, with ...
OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback